Proctozone-g Suppository
Product Images NDC 57237-338

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Proctozone-g (NDC 57237-338). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Proctozone-g 1.2g 57237-338-21 Fig-1 (Proctozone G 1.2g 57237 338 21 Fig 1)

Drug Facts text panel for Proctozone-G suppository with 1.2 g glycerin. Includes active ingredient, purpose, uses, warnings, directions, storage, and inactive ingredients. Provides dosage for adults and children 2 years or older, cautionary statements, and instructions for use and storage.*

FDA Label Image

Proctozone-g 1.2g 57237-338-21 Fig-2 (Proctozone G 1.2g 57237 338 21 Fig 2)

Proctozone-G Glycerin Suppositories 1.2 g rectal laxative for children ages 2 to 5 years. The label indicates 12 comfort-shaped suppositories in the package, marketed by Rising Pharma Holdings, Inc. The product highlights fast relief in minutes and emphasizes safety, gentleness, and convenience for kids. The packaging features cartoon illustrations of children and a white suppository image.*

FDA Label Image

12005007 Proctozone G 1.2 G Front Foil (12005007 Proctozone G 1.2 G Front Foil)

Packaging label artwork for Proctozone-G Glycerin Suppository 1.2 g by Rising Pharma Holdings, Inc. This label includes branding, product name, route indication "For rectal use only," NDC number 57237-338, and space for embossed lot number and expiration date on foil blister packaging. The layout shows multiple repeated label units with dimensions.*

FDA Label Image

12005006 Proctozone G 1.2 G Back Foil (12005006 Proctozone G 1.2 G Back Foil)

Proctozone-G 1.2 g rectal suppository label showing multiple printed units arranged in a sheet format. Each unit includes the product name, producer Rising Pharma Holdings, Inc., storage instructions (store at 20-25°C), and a barcode. The layout indicates repeat length and spacing measurements for manufacturing purposes.*

FDA Label Image

13011263 Proctozone G 1.2 G Carton-22 (13011263 Proctozone G 1.2 G Carton 22)

Proctozone-G 1.2 g glycerin rectal suppository label showing drug facts including active ingredient, purpose, uses, warnings, directions for use, and storage instructions. The label includes a diagram of suppository insertion and manufacturer details for Rising Pharma Holdings, Inc. The package also displays a QR code and lot/expiration placeholders.*

FDA Label Image

13011264 Proctozone G 1.2 Carton-1 (13011264 Proctozone G 1.2 Carton 1)

Proctozone-G Glycerin Suppositories 1.2 g rectal laxative for children ages 2 to 5 years. The packaging highlights 12 comfort-shaped suppositories and features child-friendly graphics. The labeler is Rising Pharma Holdings, Inc., with manufacturing noted in India. The package emphasizes fast relief and gentle, convenient use.*

FDA Label Image

12005008 Proctozone G Front Foil (12005008 Proctozone G Front Foil)

Packaging label for Proctozone-G 1.2 g rectal suppositories by Rising Pharma Holdings, Inc. The label includes the brand name, generic name (Glycerin), NDC 57237-338, and directions for rectal use. The layout shows multiple labels for individual suppository cavities with space for batch and expiration details to be embossed.*

FDA Label Image

12005012 Proctozone G 1.2 G Back Foil (12005012 Proctozone G 1.2 G Back Foil)

Packaging label for Proctozone-G 1.2 g rectal suppository by Rising Pharma Holdings, Inc. The label includes storage instruction to keep at 20-25°C (68-77°F) and shows a barcode and distributor information repeated multiple times in a grid layout.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.